Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

Vitiligo is an acquired hypopigmentation of the skin due to a progressive selective loss of
melanocytes; it has a prevalence of 1–2% and appears as rounded, well-demarcated white …

Vitiligo is a chronic autoimmune depigmenting skin disorder that results from a loss of
melanocytes. Multiple combinatorial factors have been involved in disease development …

Importance References to the expected treatment response to phototherapy would be
helpful in the management of vitiligo because phototherapy requires long treatment …

The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo,
early factors include activation of innate immunity, inflammasome activation, oxidative stress …

Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are
safe and effective treatments available for vitiligo. It is important to recognize common and …

Vitiligo, the most common depigmenting disorder of the skin, is undergoing a period of
intense advances in both disease understanding and therapeutic possibilities leading the …

Background The treatment of vitiligo can be challenging and depends on several factors
such as the subtype, disease activity, vitiligo extent, and treatment goals. Vitiligo usually …

Vitiligo is an autoimmune skin disease mediated by autoreactive CD8+ T cells that destroy
the pigment-producing cells of the epidermis, melanocytes, leading to areas of …

Vitiligo is a common skin disorder characterized by immune‐mediated destruction of
melanocytes. Non‐segmental vitiligo, the most common clinical subtype, has usually a …